Find the IQIRVO® resource that best fits your needs
This library of downloadable materials has been specifically created to help you feel informed and empowered throughout your treatment experience with IQIRVO. Get information on IQIRVO clinical trials, the impact of IQIRVO on symptoms, and help with discussing IQIRVO at your next doctor’s appointment.
Discover PBC support organizations
Finding a community that understands the experience of living with primary biliary cholangitis (PBC) as a rare disease is important and can help you get access to additional support for you and your loved ones.
Information about these organizations is provided for convenience and is not an endorsement of these organizations by Ipsen or by these organizations of Ipsen.
ALF is dedicated to education, advocacy, support, and research about the prevention, treatment, and cure of liver diseases like PBC.
CLA invests in local communities and advocates for liver disease patients by supporting awareness, prevention, education, and research.
GLI promotes education and innovation to help cure liver diseases through a patient-centered approach.
PBCers Organization is an online and in-person support group for people with PBC, their loved ones, and their healthcare team.
PBC Foundation aims to create positive impact for people with PBC and their loved ones by providing comprehensive support and resources.
Why joining the PBC community can make a big difference
Connecting with others who live with PBC can help you feel more informed, supported, and seen during your journey. Through the PBC community, you might find:
Support from people who truly understand your experience with PBC
Practical tips and dedicated resources to help manage daily life with PBC
Empowerment and advocacy for yourself and others in the community where you feel understood, confident, and connected
“I hope that by sharing my story, I can inspire others who are living with PBC to feel empowered to advocate for themselves and their liver health.”
Wendy, person living with PBC
Frequently asked questions
“Eye-ker-vo.”
IQIRVO is a once-daily oral pill used to treat primary biliary cholangitis (PBC) in adults.
IQIRVO is indicated for adults with primary biliary cholangitis (PBC). IQIRVO is an add-on treatment, meaning it is taken alongside ursodiol.a However, in people who are unable to take ursodiol, IQIRVO can be taken alone.
Talk to your doctor to see if IQIRVO is right for you.
aUrsodeoxycholic acid, or ursodiol, may also be referred to as UDCA.
IQIRVO is thought to act on multiple targets in the liver. Two of these targets are PPAR alpha and PPAR delta.b In the liver, PPAR alpha and PPAR delta help control liver inflammation and levels of certain substances, like bile acids.
bThis information is based on animal studies, and the way IQIRVO works is not fully understood.
PPAR=peroxisome proliferator–activated receptor.
IQIRVO is taken once daily as an oral pill.
IQIRVO can be taken with or without food.
See your doctor for more specific dosing instructions and regimens.
IQIRVO should be stored in its original packaging at room temperature. Keep IQIRVO out of reach of children.
Talk to your doctor about starting IQIRVO. IPSEN CARES® patient support program can help you get access to your IQIRVO prescription with the information and support you need. To learn more about IPSEN CARES, visit www.ipsencares.com.
Some people taking IQIRVO may be eligible for a $0 copay.c Learn more about financial assistance at www.ipsencares.com.
Learn about accessing IQIRVO at www.ipsencares.com.
Every patient’s health insurance coverage benefit is unique. IPSEN CARES® can help verify patients’ coverage for IQIRVO. Furthermore, for people taking IQIRVO, IPSEN CARES can identify and communicate coverage requirements as well as the patient’s out-of-pocket responsibilities.
Please call IPSEN CARES at (866) 435-5677 Monday through Friday 8:00 AM to 8:00 PM ET for assistance.
Glossary of terms
Alkaline phosphatase, an enzyme found in the liver. High levels of ALP in the blood are associated with liver diseases like PBC. This marker can be used to track response to treatment.
A component of bile. High levels of bilirubin indicate advanced disease in PBC. Regular measurement of bilirubin can be used to track PBC disease progression and response to treatment.
Primary biliary cholangitis, a chronic autoimmune liver disease.
Peroxisome proliferator–activated receptor.
Ursodeoxycholic acid, also known as ursodiol. It is the standard first treatment option for people with PBC.
The upper limit of normal, or ULN, is the high end of a normal range for a lab value. When assessing a patient's response to treatment for PBC, the definition of response may include an ALP level in relation to the ULN (for example, an ALP level of 1.67 x ULN).
c Patient Eligibility & Terms and Conditions: Patients are not eligible for copay assistance through IPSEN CARES if they are enrolled in any state or federally funded programs for which drug prescriptions or coverage could be paid in part or in full, including, but not limited to, Medicare Part B, Medicare Part D, Medicaid, Medigap, VA, DoD, or TRICARE (collectively, “Government Programs”), or where prohibited by law. Patients must be United States residents (including its territories) and enrolled in IPSEN CARES to receive copay program benefits. Patients receiving assistance through another assistance program or foundation, free trial, or other similar offer or program, are not eligible for the copay assistance program during the current enrollment year. An annual calendar year maximum copay benefit applies. Patients may remain enrolled in copay assistance as long as eligibility criteria is met. Patients or guardians are responsible for reporting receipt of copay savings benefit to any insurer, health plan, or other third party who pays for or reimburses any part of the prescription filled through the program, as may be required. Additionally, patients or guardians may not submit any benefit provided by this program for reimbursement through a Flexible Spending Account, Health Savings Account, Health Reimbursement Account, or otherwise to a government or private payor. Ipsen reserves the right to rescind, revoke, or amend these offers without notice at any time. Ipsen and/or its copay assistance vendor are not responsible for any transactions processed under this program where Medicaid, Medicare, or Medigap payment in part or full has been applied. Data related to patient participation may be collected, analyzed, and shared with Ipsen for market research and other purposes related to assessing the program. Data shared with Ipsen will be de-identified, meaning it will not identify the patient. Void outside of the United States and its territories or where prohibited by law, taxed, or restricted. This program is not health insurance. No other purchase is necessary. Copay assistance cannot be sold, purchased, traded, or counterfeited. Void if reproduced.